| Phase 1 trials of rVSV Ebola vaccine in Africa and Europe ST Agnandji, A Huttner, ME Zinser, P Njuguna, C Dahlke, JF Fernandes, ... New England Journal of Medicine 374 (17), 1647-1660, 2016 | 500 | 2016 |
| Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection against Plasmodium falciparum infection in Kenyan adults C Ogwang, D Kimani, NJ Edwards, R Roberts, J Mwacharo, G Bowyer, ... Science translational medicine 7 (286), 286re5-286re5, 2015 | 160 | 2015 |
| Circumsporozoite-specific T cell responses in children vaccinated with RTS, S/AS01E and protection against P falciparum clinical malaria A Olotu, P Moris, J Mwacharo, J Vekemans, D Kimani, M Janssens, O Kai, ... PloS one 6 (10), e25786, 2011 | 111 | 2011 |
| Optimising controlled human malaria infection studies using cryopreserved P. falciparum parasites administered by needle and syringe SH Sheehy, AJ Spencer, AD Douglas, BKL Sim, RJ Longley, NJ Edwards, ... PloS one 8 (6), e65960, 2013 | 110 | 2013 |
| Evaluating controlled human malaria infection in Kenyan adults with varying degrees of prior exposure to Plasmodium falciparum using sporozoites administered … SH Hodgson, E Juma, A Salim, C Magiri, D Kimani, D Njenga, A Muia, ... Frontiers in microbiology 5, 686, 2014 | 108 | 2014 |
| Safety and Immunogenicity of Heterologous Prime-Boost Immunisation with Plasmodium falciparum Malaria Candidate Vaccines, ChAd63 ME-TRAP and MVA ME … C Ogwang, M Afolabi, D Kimani, YJ Jagne, SH Sheehy, CM Bliss, ... PloS one 8 (3), e57726, 2013 | 98 | 2013 |
| Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populations D Kimani, YJ Jagne, M Cox, E Kimani, CM Bliss, E Gitau, C Ogwang, ... Molecular Therapy 22 (11), 1992-2003, 2014 | 70 | 2014 |
| Detecting malaria hotspots: a comparison of rapid diagnostic test, microscopy, and polymerase chain reaction P Mogeni, TN Williams, I Omedo, D Kimani, JM Ngoi, J Mwacharo, ... The Journal of infectious diseases 216 (9), 1091-1098, 2017 | 58 | 2017 |
| A statistical interaction between circumsporozoite protein-specific T cell and antibody responses and risk of clinical malaria episodes following vaccination with RTS, S/AS01E FM Ndungu, J Mwacharo, D Kimani, O Kai, P Moris, E Jongert, ... PLoS One 7 (12), e52870, 2012 | 52 | 2012 |
| Repeated clinical malaria episodes are associated with modification of the immune system in children Y Bediako, R Adams, AJ Reid, JJ Valletta, FM Ndungu, J Sodenkamp, ... BMC medicine 17, 1-14, 2019 | 48 | 2019 |
| Increased sample volume and use of quantitative reverse-transcription PCR can improve prediction of liver-to-blood inoculum size in controlled human malaria infection studies SH Hodgson, AD Douglas, NJ Edwards, D Kimani, SC Elias, M Chang, ... Malaria Journal 14, 1-9, 2015 | 46 | 2015 |
| High efficiency human memory B cell assay and its application to studying Plasmodium falciparum-specific memory B cells in natural infections GE Weiss, FM Ndungu, N McKittrick, S Li, D Kimani, PD Crompton, ... Journal of immunological methods 375 (1-2), 68-74, 2012 | 43 | 2012 |
| Plasmodium falciparum malaria parasite var gene expression is modified by host antibodies: longitudinal evidence from controlled infections of Kenyan adults with … AI Abdi, SH Hodgson, MK Muthui, CA Kivisi, G Kamuyu, D Kimani, ... BMC Infectious Diseases 17, 1-11, 2017 | 34 | 2017 |
| Lack of avidity maturation of merozoite antigen-specific antibodies with increasing exposure to Plasmodium falciparum amongst children and adults exposed to endemic malaria in … F Ibison, A Olotu, DM Muema, J Mwacharo, E Ohuma, D Kimani, K Marsh, ... PLoS One 7 (12), e52939, 2012 | 34 | 2012 |
| CD4+ T cell responses to the Plasmodium falciparum erythrocyte membrane protein 1 in children with mild malaria EN Gitau, J Tuju, H Karanja, L Stevenson, P Requena, E Kimani, A Olotu, ... The Journal of Immunology 192 (4), 1753-1761, 2014 | 26 | 2014 |
| Pooled testing conserves SARS-CoV-2 laboratory resources and improves test turn-around time: experience on the Kenyan Coast CN Agoti, M Mutunga, AW Lambisia, D Kimani, R Cheruiyot, P Kiyuka, ... Wellcome open research 5, 2020 | 23 | 2020 |
| Safety and PCR monitoring in 161 semi-immune Kenyan adults following controlled human malaria infection MC Kapulu, P Njuguna, M Hamaluba, D Kimani, JM Ngoi, J Musembi, ... JCI insight 6 (17), 2021 | 19 | 2021 |
| Controlled human malaria infection (CHMI) outcomes in Kenyan adults is associated with prior history of malaria exposure and anti-schizont antibody response MC Kapulu, D Kimani, P Njuguna, M Hamaluba, E Otieno, R Kimathi, ... BMC infectious diseases 22 (1), 86, 2022 | 17 | 2022 |
| An optimization of four SARS-CoV-2 qRT-PCR assays in a Kenyan laboratory to support the national COVID-19 rapid response teams KS Mohammed, ZR de Laurent, DO Omuoyo, C Lewa, E Gicheru, ... Wellcome open research 5, 2020 | 13 | 2020 |
| Spatio-temporal distribution of antimalarial drug resistant gene mutations in a Plasmodium falciparum parasite population from Kilifi, Kenya: A 25-year … I Omedo, B Bartilol, D Kimani, S Gonçalves, E Drury, MK Rono, AI Abdi, ... Wellcome Open Research 7, 45, 2022 | 9 | 2022 |
